Although the trial against Takeda Pharmaceuticals, manufacturers of the controversial diabetes drug Actos, continues to heat up Food and Drug Administration (FDA) and the European Medicines Agency have not issued recalls of the drug.
In 2011, citing strong evidence of Actos’s link to bladder cancer, as well as heart failure, France and Germany issued recalls.
Later in 2011, the lawsuits against Takeda Pharmaceuticals were consolidated into one suit, Multidistrict Litigation (MDL) 2299, in the US District Court of Louisiana (Lafayette). Judge Rebecca Doherty presides over the case.
The FDA did issue a stronger warning on Actos, called a black box warning. This is the strongest label a drug can receive from the FDA. The European Medicines Agency has not issued a similar warning, although their website lists some of the detrimental side effects of using the drug.
For more information on a potential Actos recall, please continue to check the Strom Law Blog. The Strom Law Firm, LLC, has experienced lawyers who can help you if you or a loved one have been diagnosed with bladder cancer, congenital heart failure, or liver failure as a result of taking Actos. Contact us for a free consultation. 803.252.4800